SMTL ID : 3u2c.1

Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolution

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.00 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 33 residues within 4Å: Chain A: G.19, T.20, W.21, K.22, D.44, Y.49, K.78, H.111, W.112, S.160, N.161, Q.184, Y.210, S.211, P.212, L.213, G.214, S.215, P.216, D.217, L.229, A.246, I.261, P.262, K.263, S.264, V.265, T.266, R.269, E.272, N.273, C.299 Ligands: SUZ.6 30 PLIP interactions: 30 interactions with chain A Hydrophobic interactions: A:W.21 Hydrogen bonds: A:T.20, A:W.21, A:D.44, A:D.44, A:Y.49, A:S.160, A:N.161, A:Q.184, A:S.211, A:L.213, A:S.215, A:S.215, A:D.217, A:D.217, A:K.263, A:K.263, A:V.265, A:T.266, A:T.266, A:E.272, A:N.273 Water bridges: A:T.244, A:A.246, A:R.269 Salt bridges: A:K.22, A:K.263, A:R.269 pi-Stacking: A:Y.210 pi-Cation interactions: A:R.269

2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.2: 2 residues within 4Å: Chain A: Q.201, N.257 2 PLIP interactions: 2 interactions with chain A Water bridges: A:Q.201, A:G.204 PEG.7: 6 residues within 4Å: Chain A: A.2, I.15, R.251, M.254, N.257, F.277 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.251, A:R.251, A:N.257

2 x PG5: 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE(Non-covalent)

PG5.3: 2 residues within 4Å: Chain A: P.232, R.233 No protein-ligand interaction detected (PLIP) PG5.4: 3 residues within 4Å: Chain A: N.53, K.95, D.99 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:K.95 Water bridges: A:N.53, A:D.99, A:D.99

1 x CIT: CITRIC ACID(Non-functional Binders)

CIT.5: 7 residues within 4Å: Chain A: W.220, C.299, A.300, L.301, L.302, S.303 Ligands: SUZ.6 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:W.220, A:W.220 Hydrogen bonds: A:A.300, A:L.301, A:L.302, A:S.303

1 x SUZ: [(1Z)-5-fluoro-2-methyl-1-{4-[methylsulfinyl]benzylidene}-1H-inden-3-yl]acetic acid(Non-covalent)

SUZ.6: 11 residues within 4Å: Chain A: W.21, V.48, Y.49, H.111, W.112, F.123, W.220, C.299, S.303 Ligands: NAP.1, CIT.5 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:W.21, A:W.21, A:Y.49, A:W.112, A:F.123, A:W.220 Salt bridges: A:K.78, A:H.111 pi-Stacking: A:F.123 pi-Cation interactions: A:F.123 Halogen bonds: A:V.48

1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)

PG4.8: 2 residues within 4Å: Chain A: Q.60, K.101 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Q.60

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Steuber, H., An old NSAID revisited: crystal structure of aldose reductase in complex with sulindac at 1.0 A supports a novel mechanism for its anticancer and antiproliferative effects. Chemmedchem (2011)

Release Date

2011-11-02

Peptides

Aldose reductase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Aldose reductase

Related Entries With Identical Sequence